Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Jaguar Health Inc (NASDAQ: JAGX) closed at $0.21 in the last session, up 3.22% from day before closing price of $0.21. In other words, the price has increased by $3.22 from its previous closing price. On the day, 99.37 million shares were traded. JAGX stock price reached its highest trading level at $0.253 during the session, while it also had its lowest trading level at $0.2091.
Ratios:
We take a closer look at JAGX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 2.00. In the meantime, Its Debt-to-Equity ratio is 7.48 whereas as Long-Term Debt/Eq ratio is at 6.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 07, 2021, initiated with a Overweight rating and assigned the stock a target price of $5.
On July 11, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAGX now has a Market Capitalization of 61666992 and an Enterprise Value of 89864632. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.08 while its Price-to-Book (P/B) ratio in mrq is 3.17. Its current Enterprise Value per Revenue stands at 9.206 whereas that against EBITDA is -2.816.
Stock Price History:
The Beta on a monthly basis for JAGX is 1.06, which has changed by -0.6214789 over the last 52 weeks, in comparison to a change of 0.23099434 over the same period for the S&P500. Over the past 52 weeks, JAGX has reached a high of $1.22, while it has fallen to a 52-week low of $0.05. The 50-Day Moving Average of the stock is 116.80%, while the 200-Day Moving Average is calculated to be -16.00%.
Shares Statistics:
According to the various share statistics, JAGX traded on average about 61.11M shares per day over the past 3-months and 64882500 shares per day over the past 10 days. A total of 276.22M shares are outstanding, with a floating share count of 262.69M. Insiders hold about 4.90% of the company’s shares, while institutions hold 0.76% stake in the company. Shares short for JAGX as of 1713139200 were 14360777 with a Short Ratio of 0.23, compared to 1710460800 on 7444637. Therefore, it implies a Short% of Shares Outstanding of 14360777 and a Short% of Float of 5.0.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$9. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
According to 1 analysts, the current quarter’s revenue is expected to be $2.3M. It ranges from a high estimate of $2.61M to a low estimate of $2.61M. As of the current estimate, Jaguar Health Inc’s year-ago sales were $3.26MFor the next quarter, 1 analysts are estimating revenue of $2.76M. There is a high estimate of $2.76M for the next quarter, whereas the lowest estimate is $2.76M.
A total of 1 analysts have provided revenue estimates for JAGX’s current fiscal year. The highest revenue estimate was $9.32M, while the lowest revenue estimate was $9.32M, resulting in an average revenue estimate of $9.76M. In the same quarter a year ago, actual revenue was $11.96MBased on 1 analysts’ estimates, the company’s revenue will be $13.81M in the next fiscal year. The high estimate is $13.81M and the low estimate is $13.81M.
